First case of COVID‐19 in a kidney transplant recipient treated with belatacept
Author:
Affiliation:
1. Department of Nephrology and Transplantation Strasbourg University Hospital Strasbourg France
2. Department of Virology Strasbourg University Hospital Strasbourg France
Publisher
Wiley
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15919
Reference6 articles.
1. Clinical characteristics of coronavirus disease 2019 in China;Guan W;N Engl J Med
2. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study;Zhou F;Lancet
3. Opportunistic infections after conversion to belatacept in kidney transplantation
4. World Health Organization.Clinical management of severe acute respiratory infection (SARI) when Covid‐19 disease is suspected. Interim guidance 13 March 2020.https://www.who.int/publications‐detail/clinical‐management‐of‐severe‐acute‐respiratory‐infection‐when‐novel‐coronavirus‐(ncov)‐infection‐is‐suspected. Accessed April 20 2020.
5. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of the coronavirus pandemic on living-donor organ transplantation;Living Donor Organ Transplantation;2024
2. A Pilot Randomized Controlled Trial of De Novo Belatacept-based Immunosuppression After Lung Transplantation;Transplantation;2023-10-30
3. COVID-19 en receptores de trasplante: reporte multicéntrico de la experiencia mexicana;Archivos de Cardiología de México;2023-09-05
4. SARS-CoV-2 Infection of Unvaccinated Liver- and Kidney-Transplant Recipients: A Single-Center Experience of 103 Consecutive Cases;Transplantology;2022-06-16
5. Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients;Transplantation Direct;2022-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3